Jump to main content
Jump to site search

Issue 6, 2012
Previous Article Next Article

Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats

Author affiliations

Abstract

We tested whether the administration procedure of quercetin affects its metabolite profile and antihypertensive activity. Spontaneously hypertensive rats (SHR) were randomly assigned to four experimental treatments: (1) 1 mL of 1% methylcellulose by oral gavage and 2% DMSO i.p. (control group); (2) 10 mg kg−1 quercetin by oral gavage once daily and 2% DMSO i.p.; (3) 10 mg kg−1 quercetin by oral gavage divided in two daily doses (5 + 5 at 12 h intervals) and 2% DMSO i.p.; (4) 1 mL of 1% methylcellulose by oral gavage and 10 mg kg−1 quercetin i.p. injection. Rats were treated daily for 5 weeks. Single dose and two daily doses, in a long-term oral treatment were equally efficient, both restoring the impaired aortic endothelium-dependent vasodilatation and reducing mesenteric contractile response to phenylephrine, systolic blood pressure, heart rate, and heart and kidney hypertrophy. Attenuation of vascular NADPH oxidase-driven O2 production was also found in orally treated rats. Intraperitoneal administration reduced, to lesser extent than oral administration, the increased systolic blood pressure, being without effect to the endothelial dysfunction and vascular oxidative stress. In contrast, greater levels of metabolites were quantified following intraperitoneal compared to oral administration at any time point, except for higher plasma methylated quercetin aglycone in oral as compared to intraperitoneal administration at 2 but not at 8 h. In conclusion, oral quercetin was superior to intraperitoneal administration for the protection from cardiovascular complications in SHR. No differences were found between the oral administration as a single daily dose or divided into two daily doses.

Graphical abstract: Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats

Back to tab navigation

Publication details

The article was received on 30 Nov 2011, accepted on 05 Mar 2012 and first published on 23 Mar 2012


Article type: Paper
DOI: 10.1039/C2FO10268D
Citation: Food Funct., 2012,3, 643-650
  •   Request permissions

    Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats

    P. Galindo, S. González-Manzano, M. J. Zarzuelo, M. Gómez-Guzmán, A. M. Quintela, A. González-Paramás, C. Santos-Buelga, F. Pérez-Vizcaíno, J. Duarte and R. Jiménez, Food Funct., 2012, 3, 643
    DOI: 10.1039/C2FO10268D

Search articles by author

Spotlight

Advertisements